Defense Personnel Support Center, 2800 S 20Th Street, Phila PA 19101-8419

65 -- TREATMENT OF PEDIATRIC AND ADULT ASTHMA SOL SP0200-95-1011 DUE 091795 POC Contact: Charles Stewart Reeves, M.D. Captain, medical Corps, U.S.N.R. Navy medical consultant Commercial: 215-221-4311 FAX: 210-221-4314 Procurement Agnt, Francis Tallent, Officer mgab-peasee remarks: The pharmacoeconomic Center (PEC) is reviewing information to develop analytic methodologies to evaluate the treatment of pediatric and adult asthmain the Military Health service system. Manufacturers of products used for the treatment of asthma are invited to present pharmacoeconomic information to the PEC. This information will assist indeveloping an evaluation Model for the Tri-service formulary. Types of information being reviewed include head to head effectiveness studies of competing therapies, pharmacoeconomic and/orquality of life studies of asthma, pharmaco-epidemiological information or studies of asthma, patient outcomes studies, pharmacoeconomic modeling ofasthma, and any unpublished data relevant to the treatment of asthma. Up to one hour is the preferred length of a presentation; not more than two hours will be allotted for a presentation. Each manufacturer will be limited to one presentation on asthma. Firms who made presentations on asthmaafter January 1995 do not need to submit additionalinformation. For further information, contact Capt C. Stewart Reeves, usnr, pharmacoeconomic Center, Attn: Afzg-dl, Bldg, 4197, 2107 17th St, Ft. Samhouston, TX 78234-5036. This is a Market surveyonly. All responsible sources may submit offer which DPSC shall consider(0248)

Loren Data Corp. http://www.ld.com (SYN# 0252 19950906\65-0001.SOL)